TrialInternational journal of clinical oncology2025

A phase two trial evaluating FOLFIRI plus aflibercept after failure of FOLFOXIRI plus bevacizumab in patients with unresectable metastatic colorectal cancer.

Koji Ando et al.PubMed ↗Publisher ↗

No numbers read from the abstract.